These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20558759)

  • 1. Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression.
    Wang B; Yang Z; Brisson BK; Feng H; Zhang Z; Welch EM; Peltz SW; Barton ER; Brown RH; Sweeney HL
    J Appl Physiol (1985); 2010 Sep; 109(3):901-5. PubMed ID: 20558759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
    Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
    J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes.
    Cea LA; Bevilacqua JA; Arriagada C; Cárdenas AM; Bigot A; Mouly V; Sáez JC; Caviedes P
    BMC Cell Biol; 2016 May; 17 Suppl 1(Suppl 1):15. PubMed ID: 27229680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
    Vallecillo-Zúniga ML; Rathgeber MF; Poulson PD; Hayes S; Luddington JS; Gill HN; Teynor M; Kartchner BC; Valdoz J; Stowell C; Markham AR; Arthur C; Stowell S; Van Ry PM
    PLoS One; 2020; 15(9):e0238441. PubMed ID: 32881965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.
    Kerr JP; Ziman AP; Mueller AL; Muriel JM; Kleinhans-Welte E; Gumerson JD; Vogel SS; Ward CW; Roche JA; Bloch RJ
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20831-6. PubMed ID: 24302765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane repair of human skeletal muscle cells requires Annexin-A5.
    Carmeille R; Bouvet F; Tan S; Croissant C; Gounou C; Mamchaoui K; Mouly V; Brisson AR; Bouter A
    Biochim Biophys Acta; 2016 Sep; 1863(9):2267-79. PubMed ID: 27286750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.
    Tanaka A; Woltjen K; Miyake K; Hotta A; Ikeya M; Yamamoto T; Nishino T; Shoji E; Sehara-Fujisawa A; Manabe Y; Fujii N; Hanaoka K; Era T; Yamashita S; Isobe K; Kimura E; Sakurai H
    PLoS One; 2013; 8(4):e61540. PubMed ID: 23626698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
    Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
    PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.
    Cohen TV; Cohen JE; Partridge TA
    Neuromuscul Disord; 2012 Jul; 22(7):648-58. PubMed ID: 22560623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.
    Rawat R; Cohen TV; Ampong B; Francia D; Henriques-Pons A; Hoffman EP; Nagaraju K
    Am J Pathol; 2010 Jun; 176(6):2891-900. PubMed ID: 20413686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair.
    Matsuda C; Kiyosue K; Nishino I; Goto Y; Hayashi YK
    PLoS Curr; 2015 Oct; 7():. PubMed ID: 26579332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
    Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
    Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraspanin CD82 Associates with Trafficking Vesicle in Muscle Cells and Binds to Dysferlin and Myoferlin.
    Fontelonga T; Hall AJ; Brown JL; Jung YL; Alexander MS; Dominov JA; Mouly V; Vieira N; Zatz M; Vainzof M; Gussoni E
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300157. PubMed ID: 37434585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.